Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination

Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination

Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have reduced susceptibility to neutralization by vaccines. In response to the constantly updated variants, a global vaccine booster vaccination program has been launched. In this study, we detected neutralizing antibody l...

Full description

Bibliographic Details
Main Authors: Jianhua Li, Xiaoyan Li, Erqiang Wang, Jinye Yang, Jiaxuan Li, Chen Huang, Yanjun Zhang, Keda Chen
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Vaccines
Subjects:
neutralizing antibodies
CoronaVac
SARS-CoV-2
booster dose
Online Access:https://www.mdpi.com/2076-393X/10/12/2111

Internet

https://www.mdpi.com/2076-393X/10/12/2111

Similar Items